CSIC

Ring of Fire Metals Progresses Sustainable Mine Studies

Retrieved on: 
Tuesday, November 1, 2022
Atmosphere, CSIRO, CSIC, Nickel, Spanish National Research Council, PGE, Ring of Fire, Collection, Technology, Biomass, Weather, Palladium, Season, Consejo Superior de los Colegios de Arquitectos de España, CO2, Vaisala, Wind, Cobalt, Copper, Carbon, Platinum, Geosciences Barcelona (GEO3BCN), Metal, Nest, Renewable energy, Iron ore, Eagle, Andrew Forrest

TORONTO, Nov. 1, 2022 /CNW/ - Ring of Fire Metals (RoF Metals) has commenced two studies exploring the use of wind power and atmospheric carbon removal as part of planning for a net zero emissions mine in Northern Ontario's Ring of Fire.

Key Points: 
  • TORONTO, Nov. 1, 2022 /CNW/ - Ring of Fire Metals (RoF Metals) has commenced two studies exploring the use of wind power and atmospheric carbon removal as part of planning for a net zero emissions mine in Northern Ontario's Ring of Fire.
  • Following completion of the Windlab study, RoF Metals installed a Vaisala WindCube lidar for the collection of more detailed data.
  • Ring of Fire Metals does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such statements.
  • Ring of Fire Metals holds the most important mineral deposits in the Ring of Fire region, located in the James Bay Lowlands of Northern Ontario.

ABARCA PRIZE RECOGNIZES MEDICAL-SCIENTIFIC RESEARCH IN ITS 2ND EDITION, BY HM HOSPITALES

Retrieved on: 
Friday, October 28, 2022
Dysentery, Lists of countries and territories, Institut Pasteur Korea, Disease, Vaccine, Death, Rockefeller University, Shigella, Diarrhea, Multimedia, Shigellosis, Pasteur Institute, Research, CSIC, Cell biology, Scientific method, Medicine, WHO, Biology, Health, Pharmaceutical industry

The 'ABARCA PRIZE' award ceremony held in Madrid (Spain) brought together more than 130 guests and renowned public figures.

Key Points: 
  • The 'ABARCA PRIZE' award ceremony held in Madrid (Spain) brought together more than 130 guests and renowned public figures.
  • The ABARCA PRIZE is endowed with 100,000 euros and an accrediting diploma.
  • Professor Sansonetti said "It is an honor to be awarded the ABARCA PRIZE.
  • The 'ABARCA PRIZE' Award began in 2021 to highlight on the international stage the impact of medical-scientific advances and innovations.

C&S Specialty Underwriters, LLC Announces New Program Partnership with CUMIS Specialty Insurance Company, Inc.

Retrieved on: 
Thursday, September 1, 2022
Other Professional Services, Professional Services, Insurance, Finance, Partnership, Commercial general liability insurance, College of Healthcare Information Management Executives, Program, Commercial, CUNA Mutual Group, LLC, C&S, Knowledge, CSIC, Reinsurance, Insurance

C&S Specialty Underwriters, LLC (C&S) announced today that it has entered into a Program Administration Agreement with CUMIS Specialty Insurance Company, Inc. (CSIC) to underwrite Commercial General Liability insurance for specialty construction risks.

Key Points: 
  • C&S Specialty Underwriters, LLC (C&S) announced today that it has entered into a Program Administration Agreement with CUMIS Specialty Insurance Company, Inc. (CSIC) to underwrite Commercial General Liability insurance for specialty construction risks.
  • Commenting on the announcement for C&S, Preston Starr, Managing Executive, said: We are excited about our new partnership with the CUNA Mutual Group, which strengthens our long-term commitment to the specialty construction market.
  • The program with CUMIS Specialty Insurance Company expands our construction capabilities throughout the U.S., including for West Coast contractors.
  • Insurance products are underwritten by CUMIS Specialty Insurance Company, Inc., a member of the CUNA Mutual Group.

AM Best Affirms Credit Ratings of Concert Insurance Group Members

Retrieved on: 
Wednesday, August 10, 2022
Insurance, Professional Services, Credit, ERM, Industry, Growth, Leadership, AM, ALL, CIC, Concert, AM Best, News, Insurance, Time, CSIC, Risk management

Collectively, these companies operate under an inter-company pooling agreement and are referred to as Concert Insurance Group (Concert).

Key Points: 
  • Collectively, these companies operate under an inter-company pooling agreement and are referred to as Concert Insurance Group (Concert).
  • Concert was founded by a group of experienced insurance industry executives in response to growing demand from the fronting market.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Performance Assessments, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .

Skye Bioscience Expands Cannabinoid Pharmaceutical Innovation Program with Leading Cannabinoid Medicinal Chemistry Groups

Retrieved on: 
Tuesday, June 7, 2022
UPO, Severe cognitive impairment, Chemistry, OTCQB, Research, CPIP, CSIC, Doctor of Philosophy, CEO, Glaucoma, Cannabinoid, CRA, University, University of Eastern Piedmont, Ophthalmology, GLOBE, DRS, Technology, Medication, IQM, Diagnosis, Thought, Department, Cell biology, Medicine, ECS, Pharmaceutical industry, Isle of Skye

San Diego, California, June 07, 2022 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing proprietary, synthetic cannabinoid derivatives to treat glaucoma and other diseases with significant unmet needs, has signed new research agreements with the University of Eastern Piedmont (UPO) in Italy and the Spanish Research Council (CSIC) that will focus on developing an extensive library of novel molecules designed to modulate the endocannabinoid system (ECS), with an initial focus on ophthalmic disorders.

Key Points: 
  • Skye launched its Cannabinoid Pharmaceutical Innovation Program (CPIP) in October 2021 to expand its cannabinoid-based science and cutting-edge research that can be commercialized through new and existing technologies.
  • Skye will sponsor the research and all intellectual property developed under this CRA will be solely owned by Skye.
  • Heading the research is Diego Caprioglio, PhD, professor in the Department of Pharmaceutical Sciences Novara Natural Product Chemistry Group (Novara) at UPO.
  • Skye Bioscience, Inc. is a pharmaceutical company unlocking the potential of cannabinoids through the development of its proprietary cannabinoid derivatives to treat diseases with significant unmet needs.

Spanish Research to Benefit from a new Read & Publish Agreement between AIP Publishing and Consejo Superior de Investigaciones Científicas (CSIC)

Retrieved on: 
Wednesday, May 11, 2022
Publishing, Open access, Unit, Communication, CSIC, Spanish National Research Council, American Institute, Partnership, APC, Knowledge, Publication, American Institute of Physics, Information, Science, View, AIP, Research, Multimedia, Pharmaceutical industry, Management

MELVILLE, N.Y., May 11, 2022 /PRNewswire/ -- AIP Publishing , a leading not-for-profit scholarly publisher in the physical sciences, is pleased to announce a partnership with Consejo Superior de Investigaciones Cientficas, the Spanish National Research Council ( CSIC ), in a three-year Read and Publish agreement.

Key Points: 
  • MELVILLE, N.Y., May 11, 2022 /PRNewswire/ -- AIP Publishing , a leading not-for-profit scholarly publisher in the physical sciences, is pleased to announce a partnership with Consejo Superior de Investigaciones Cientficas, the Spanish National Research Council ( CSIC ), in a three-year Read and Publish agreement.
  • "CSIC is delighted to be able to offer to our researchers a new route to publish Open Access through our agreement with AIP Publishing," said CSIC's Unit for Information Resources Director Agns Ponsati.
  • For this reason, we are pleased to have reached this Read and Publish agreement with AIP."
  • "We are excited to collaborate with CSIC as Spain's largest public research institution," said Penelope Lewis, AIP Publishing's Chief Publishing Officer.

AM Best Assigns Credit Ratings to Concert Specialty Insurance Company

Retrieved on: 
Tuesday, December 14, 2021
Insurance, Professional Services, ILS, Insurance, Growth, Credit, Industry, Time, Freedom, Data, Leadership, ERM, AM, CSIC, AM Best, ALL, News, Security (finance), Risk management

AM Best has assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating (Long-Term ICR) of a- (Excellent) to Concert Specialty Insurance Company (CSIC) (Helena, MT).

Key Points: 
  • AM Best has assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating (Long-Term ICR) of a- (Excellent) to Concert Specialty Insurance Company (CSIC) (Helena, MT).
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .
  • AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry.

Samyang Biopharm USA, Inc. and Spanish National Research Council (CSIC) Announce Strategic Collaboration to Study SYB-010; A First-in-Class, Immune Stimulatory Monoclonal Antibody

Retrieved on: 
Monday, August 30, 2021
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, Collaboration, LLC, Metastasis, Samyang, European Research Area, Therapy, Spanish National Research Council, Life, European, CISC, Survival, CSIC, Innovation, Ligand, Antibody, Ministry of Science and Innovation (New Zealand), Reyburn, DRS, Biology, NK, Ministry, Â, Patient, General Electric Research Laboratory, Organization, NKG2D, Material, ERA, Fine chemical, Pharmaceutical industry, the Spanish National Research Council, Samyang Biopharm USA, Inc., THE SPANISH NATIONAL RESEARCH COUNCIL, SAMYANG BIOPHARM USA, INC.

Samyang Biopharm USA, Inc. ( https://us.samyangbiopharm.com ) a subsidiary of Samyang Holdings Corp. ( https://samyangbiopharm.com/eng ), announced today that the company has entered into a research collaboration with the Spanish National Research Council (CSIC), a state agency for scientific research and technological development.

Key Points: 
  • Samyang Biopharm USA, Inc. ( https://us.samyangbiopharm.com ) a subsidiary of Samyang Holdings Corp. ( https://samyangbiopharm.com/eng ), announced today that the company has entered into a research collaboration with the Spanish National Research Council (CSIC), a state agency for scientific research and technological development.
  • We look forward to future involvement within this collaboration" said Sean McKenna, Ph.D., Vice President of Research, Samyang Biopharm USA.
  • SYB-010 is a monoclonal antibody targeting the human NKG2D-ligands, MCA/B, which has shown a clear immumodulatory effect in pre-clinical models.
  • The Spanish National Research Council is a state agency for scientific research and technological development.